Trials / Completed
CompletedNCT05679609
Incentive Spirometry in Routine Management of COPD Patients
Value of Incentive Spirometry in Routine Management of COPD Patients and Its Effect on Diaphragmatic Function
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Menoufia University · Academic / Other
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
The incentive spirometer is a device that encourages patients, with visual and other positive feedback, to maximally inflate their lungs and sustain that inflation. However, its efficacy in patients with COPD has been little documented especially in diaphragmatic function. This study tried to assess the role of incentive spirometry on Spirometric functions, Sonographic diaphragmatic function, and the scale of dyspnea in COPD patients with exacerbation and with follow-up of these parameters after 2 months.
Detailed description
Forty COPD patients were admitted with an acute exacerbation and the patients were divided randomly into 2 equal groups: the first used the incentive spirometer together with medical treatment (according to GOLD guidelines) for 2 months and the second received only medical treatment for 2 months. All participants, on admission, underwent assessment of mMRC dyspnea scale, spirometry, arterial blood gases, and diaphragmatic ultrasound. Then, a follow-up of the participants was done after 2 months with the same parameters and a comparison between both groups was done.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | incentive spirometry | It is flow-oriented that has 3 chambers, (600, 900, and 1200 cc/s) and it has a mouthpiece and a ball in each chamber. After a quiet exhalation, each participant was instructed to take slow full inspirations and to keep as long as he can for at least 5 seconds, then he slowly expires. The device is used every hour at least 5 to 10 times in the session during wake time. |
Timeline
- Start date
- 2021-03-01
- Primary completion
- 2022-05-01
- Completion
- 2022-07-01
- First posted
- 2023-01-11
- Last updated
- 2023-01-11
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05679609. Inclusion in this directory is not an endorsement.